vs
FITLIFE BRANDS, INC.（FTLF）与Regencell Bioscience Holdings Ltd（RGC）财务数据对比。点击上方公司名可切换其他公司
FitLife Brands, Inc.是一家健康保健企业，主营营养补充剂、运动营养产品及体重管理解决方案的研发、营销与分销，通过零售及电商渠道服务北美地区的健身爱好者、运动员及健康意识较强的消费群体。
Regencell Bioscience Holdings Ltd是一家生物科技企业，专注于研发及商业化源自传统中药的治疗产品，核心管线覆盖神经退行性疾病、免疫类疾病等适应症，主要运营市场包括大中华区及其他亚洲区域。
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收
FTLF
RGC
| Q4 25 | $25.9M | — | ||
| Q3 25 | $23.5M | — | ||
| Q2 25 | $16.1M | — | ||
| Q1 25 | $15.9M | — | ||
| Q4 24 | $15.0M | — | ||
| Q3 24 | $16.0M | — | ||
| Q2 24 | $16.9M | — | ||
| Q1 24 | $16.5M | — |
净利润FTLFRGC
| Q4 25 | $1.6M | — | ||
| Q3 25 | $921.0K | — | ||
| Q2 25 | $1.7M | — | ||
| Q1 25 | $2.0M | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $2.1M | — | ||
| Q2 24 | $2.6M | — | ||
| Q1 24 | $2.2M | — |
毛利率FTLFRGC
| Q4 25 | 34.5% | — | ||
| Q3 25 | 37.2% | — | ||
| Q2 25 | 42.8% | — | ||
| Q1 25 | 43.1% | — | ||
| Q4 24 | 41.4% | — | ||
| Q3 24 | 43.8% | — | ||
| Q2 24 | 44.8% | — | ||
| Q1 24 | 44.0% | — |
营业利润率FTLFRGC
| Q4 25 | 8.8% | — | ||
| Q3 25 | 9.9% | — | ||
| Q2 25 | 15.6% | — | ||
| Q1 25 | 18.6% | — | ||
| Q4 24 | 19.2% | — | ||
| Q3 24 | 19.9% | — | ||
| Q2 24 | 21.7% | — | ||
| Q1 24 | 20.4% | — |
净利率FTLFRGC
| Q4 25 | 6.3% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | 10.8% | — | ||
| Q1 25 | 12.7% | — | ||
| Q4 24 | 13.8% | — | ||
| Q3 24 | 13.3% | — | ||
| Q2 24 | 15.5% | — | ||
| Q1 24 | 13.1% | — |
每股收益（稀释后）FTLFRGC
| Q4 25 | $0.16 | — | ||
| Q3 25 | $0.09 | — | ||
| Q2 25 | $0.18 | — | ||
| Q1 25 | $0.20 | — | ||
| Q4 24 | $0.22 | — | ||
| Q3 24 | $0.21 | — | ||
| Q2 24 | $0.27 | — | ||
| Q1 24 | $0.21 | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
